140 related articles for article (PubMed ID: 18034767)
1. Anti-beta 2 glycoprotein I antibodies and the risk of myocardial infarction in young premenopausal women.
Meroni PL; Peyvandi F; Foco L; Bernardinelli L; Fetiveau R; Mannucci PM; Tincani A
J Thromb Haemost; 2007 Dec; 5(12):2421-8. PubMed ID: 18034767
[TBL] [Abstract][Full Text] [Related]
2. Anti-beta 2-glycoprotein I antibodies of IgM class are linked to thrombotic disorders in young women without autoimmune disease.
Salobir B; Sabovic M; Hojnik M; Cucnik S; Kveder T
Immunobiology; 2007; 212(3):193-9. PubMed ID: 17412286
[TBL] [Abstract][Full Text] [Related]
3. Elevated IgA antiphospholipid antibodies in healthy pregnant women in Sudan but not Sweden, without corresponding increase in IgA anti-β
Elbagir S; Mohammed NA; Kaihola H; Svenungsson E; Gunnarsson I; Manivel VA; Pertsinidou E; Elagib EM; Nur MAM; Elussein EA; Elshafie A; Åkerud H; Rönnelid J
Lupus; 2020 Apr; 29(5):463-473. PubMed ID: 32106789
[TBL] [Abstract][Full Text] [Related]
4. Anti-beta2 glycoprotein-I antibody increases the risk of pregnancy-induced hypertension: a case-controlled study.
Yamada H; Atsumi T; Amengual O; Koike T; Furuta I; Ohta K; Kobashi G
J Reprod Immunol; 2010 Jan; 84(1):95-9. PubMed ID: 20004024
[TBL] [Abstract][Full Text] [Related]
5. Frequency and clinical correlates of antiphospholipid antibodies arising in patients with SARS-CoV-2 infection: findings from a multicentre study on 122 cases.
Gatto M; Perricone C; Tonello M; Bistoni O; Cattelan AM; Bursi R; Cafaro G; De Robertis E; Mencacci A; Bozza S; Vianello A; Iaccarino L; Gerli R; Doria A; Bartoloni E
Clin Exp Rheumatol; 2020; 38(4):754-759. PubMed ID: 32723434
[TBL] [Abstract][Full Text] [Related]
6. Antiphospholipid antibodies in acute coronary syndrome.
Veres K; Lakos G; Kerényi A; Szekanecz Z; Szegedi G; Shoenfeld Y; Soltész P
Lupus; 2004; 13(6):423-7. PubMed ID: 15303568
[TBL] [Abstract][Full Text] [Related]
7. IgA anticardiolipin and IgA anti-β2 glycoprotein I antibody positivity determined by fluorescence enzyme immunoassay in primary antiphospholipid syndrome.
Mattia E; Ruffatti A; Tonello M; Meneghel L; Robecchi B; Pittoni M; Gallo N; Salvan E; Teghil V; Punzi L; Plebani M
Clin Chem Lab Med; 2014 Sep; 52(9):1329-33. PubMed ID: 24651022
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of antiphospholipid antibodies in leprosy: evaluation of antigen reactivity.
de Larrañaga GF; Forastiero RR; Martinuzzo ME; Carreras LO; Tsariktsian G; Sturno MM; Alonso BS
Lupus; 2000; 9(8):594-600. PubMed ID: 11035434
[TBL] [Abstract][Full Text] [Related]
9. Immunoglobulin A anti-phospholipid antibodies in Swedish cases of systemic lupus erythematosus: associations with disease phenotypes, vascular events and damage accrual.
Frodlund M; Vikerfors A; Grosso G; Skogh T; Wetterö J; Elvin K; Gunnarsson I; Kastbom A; Dahlström Ö; Rönnelid J; Svenungsson E; Sjöwall C
Clin Exp Immunol; 2018 Oct; 194(1):27-38. PubMed ID: 30208508
[TBL] [Abstract][Full Text] [Related]
10. Identification of high thrombotic risk triple-positive antiphospholipid syndrome patients is dependent on anti-cardiolipin and anti-β2glycoprotein I antibody detection assays.
Chayoua W; Kelchtermans H; Moore GW; Musiał J; Wahl D; de Laat B; Devreese KMJ
J Thromb Haemost; 2018 Oct; 16(10):2016-2023. PubMed ID: 30079628
[TBL] [Abstract][Full Text] [Related]
11. The association between IgG and IgM antibodies against cardiolipin, β2-glycoprotein I and Domain I of β2-glycoprotein I with disease profile in patients with multiple sclerosis.
Filippidou N; Krashias G; Pericleous C; Rahman A; Ioannou Y; Giles I; Demetriou C; Anatolitou A; Christodoulou C; Pantzaris M; Lambrianides A
Mol Immunol; 2016 Jul; 75():161-7. PubMed ID: 27289032
[TBL] [Abstract][Full Text] [Related]
12. High IgA antiphospholipid autoantibodies in healthy Sudanese explain the increased prevalence among Sudanese compared to Swedish systemic lupus erythematosus patients.
Elbagir S; Elshafie AI; Elagib EM; Mohammed NA; Aledrissy MI; Manivel VA; Pertsinidou E; Nur MA; Gunnarsson I; Svenungsson E; Rönnelid J
Lupus; 2020 Oct; 29(11):1412-1422. PubMed ID: 32741301
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome.
Iwaniec T; Kaczor MP; Celińska-Löwenhoff M; Polański S; Musiał J
Thromb Res; 2017 May; 153():90-94. PubMed ID: 28363116
[TBL] [Abstract][Full Text] [Related]
14. Long-term use of hydroxychloroquine reduces antiphospholipid antibodies levels in patients with primary antiphospholipid syndrome.
Nuri E; Taraborelli M; Andreoli L; Tonello M; Gerosa M; Calligaro A; Argolini LM; Kumar R; Pengo V; Meroni PL; Ruffatti A; Tincani A
Immunol Res; 2017 Feb; 65(1):17-24. PubMed ID: 27406736
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies to the atheroma component beta2-glycoprotein I and risk of symptomatic peripheral artery disease.
Franck M; Staub HL; Petracco JB; Norman GL; Lassen AJ; Schiavo N; Borges RB; von Mühlen CA
Angiology; 2007; 58(3):295-302. PubMed ID: 17626983
[TBL] [Abstract][Full Text] [Related]
16. Biosensor analysis of beta2-glycoprotein I-reactive autoantibodies: evidence for isotype-specific binding and differentiation of pathogenic from infection-induced antibodies.
Metzger J; von Landenberg P; Kehrel M; Buhl A; Lackner KJ; Luppa PB
Clin Chem; 2007 Jun; 53(6):1137-43. PubMed ID: 17434906
[TBL] [Abstract][Full Text] [Related]
17. Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements.
Žigon P; Podovšovnik A; Ambrožič A; Tomšič M; Hočevar A; Gašperšič N; Rotar Ž; Praprotnik S; Šemrl SS; Čučnik S
Clin Rheumatol; 2019 Feb; 38(2):371-378. PubMed ID: 30099654
[TBL] [Abstract][Full Text] [Related]
18. Coexistence of anti-β2-glycoprotein I domain I and anti-phosphatidylserine/prothrombin antibodies suggests strong thrombotic risk.
Lee JS; Gu J; Park HS; Yoo HJ; Kim HK
Clin Chem Lab Med; 2017 May; 55(6):882-889. PubMed ID: 28002027
[TBL] [Abstract][Full Text] [Related]
19. A unique antiphospholipid assay recognizing phospholipid mixture compared with criteria antiphospholipid immunoassays in lupus patients.
Zuo Y; Willis R; Papalardo E; Petri M; Harris EN; Schleh A; DeCeulaer K; Smikle M; Vilá LM; Reveille JD; Alarcón GS; Gonzalez EB
Lupus; 2017 May; 26(6):606-615. PubMed ID: 27753626
[TBL] [Abstract][Full Text] [Related]
20. The clinical performance of a chemiluminescent immunoassay in detecting anti-cardiolipin and anti-β2 glycoprotein I antibodies. A comparison with a homemade ELISA method.
Meneghel L; Ruffatti A; Gavasso S; Tonello M; Mattia E; Spiezia L; Campello E; Hoxha A; Fedrigo M; Punzi L; Simioni P
Clin Chem Lab Med; 2015 Jun; 53(7):1083-9. PubMed ID: 25720075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
